Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Circularly permuted proteins and fusion proteins available for licensing

Dec. 19, 1996

Clinical trial on OXiGENE's Sensamide/Neu-Sensamide nearing completion

Dec. 19, 1996

Positive phase II results with RMP-7/carboplatin

Dec. 19, 1996

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Chemopreventive effects of Targretin in breast cancer

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

CAK1 gene for treatment and diagnosis of cancers available for licensing

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...